Event ·Multi-source

OpenAI 收购生物科技软件初创公司 Orchestra Bio

OpenAI 于当地时间周二宣布收购成立四年的 AI 生物科技软件公司 Orchestra Bio，交易条款未披露。Orchestra Bio 此前从 Andreessen Horowitz、Atria 和 8VC 等投资方累计融资约 2,000 万美元。该公司开发的 AI 智能体可帮助生物科技企业处理药物研发中的资金追踪和临床试验排期等工作。OpenAI 将把其团队与技术并入 Rosalind 项目，这是一个面向生命科学研究的 AI 模型，配套工具 Rosalind Workbench 已有 Moderna 和 Novo Nordind 等企业客户。

Current read

OpenAI 又出手了，这次买的是帮药企管临床试验排期的 Orchestra Bio，团队会并入 Rosalind 项目，Moderna 已经在用。

11 sources68° AI heatLast updated 2026/10/20 22:51:11

Evidence

11 sources

Primary sourceIT之家

2026/10/20 22:51:11View source

Related source 1rohanpaul_ai

2026/10/20 18:58:27View source

Related source 2kimmonismus

2026/10/20 21:21:35View source

Related source 3Decoder

2026/10/21 08:32:54View source

Related source 4TestingCatalog

2026/10/20 18:21:43View source

Related source 5techcrunch

2026/10/20 20:35:10View source

Related source 6OpenAI

2026/10/20 18:10:16View source

Related source 7Tech in Asia

2026/10/21 06:21:20View source

Related source 8Mark Chen (OpenAI 研究)

2026/10/20 19:33:08View source

Related source 9a16z

2026/10/19 14:37:04View source

Related source 10Latent.Space

2026/10/19 15:03:00View source

Conflict check

Dedup data only shows that these sources discuss the same event, not that they agree. There is no structured supporting or refuting evidence yet, so no conflict is inferred automatically.

Open the story